Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Brion

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
The New England Journal of Medicine|March 22, 1990
Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesisM Marty, P Pouillart, S Scholl, et al.
Chemosphere|March 14, 2018
Endocrine activity in an urban river system and the biodegradation of estrogen-like endocrine disrupting chemicals through a bio-analytical approach using DRE- and ERE-CALUX bioassaysT Vandermarken, K Croes, K Van Langenhove, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Plasma concentration of estradiol following transdermal administration of Systen 50 or Menorest 50J Y Reginster, A Albert, R Deroisy, et al.
Maturitas|June 1, 1997
Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50J Y Reginster, A Albert, R Deroisy, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
The New England Journal of Medicine|March 22, 1990
Comparison of the 5-hydroxytryptamine3 (serotonin) antagonist ondansetron (GR 38032F) with high-dose metoclopramide in the control of cisplatin-induced emesisM Marty, P Pouillart, S Scholl, et al.
Chemosphere|March 14, 2018
Endocrine activity in an urban river system and the biodegradation of estrogen-like endocrine disrupting chemicals through a bio-analytical approach using DRE- and ERE-CALUX bioassaysT Vandermarken, K Croes, K Van Langenhove, et al.
Scandinavian Journal of Rheumatology. Supplement|January 1, 1996
Plasma concentration of estradiol following transdermal administration of Systen 50 or Menorest 50J Y Reginster, A Albert, R Deroisy, et al.
Maturitas|June 1, 1997
Plasma estradiol concentrations and pharmacokinetics following transdermal application of Menorest 50 or Systen (Evorel) 50J Y Reginster, A Albert, R Deroisy, et al.
Pageof 8